Trials / Unknown
UnknownNCT03016611
Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To examine the efficacy of chewing Ticagrelor versus Prasugrel in ST-elevation Myocardial Infarction (STEMI) patients on platelet reactivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chewing Ticagrelor LD | 180 mg Chewing Ticagrelor |
| DRUG | Chewing Prasugrel LD | 60 mg Chewing Prasugrel |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2017-12-01
- First posted
- 2017-01-10
- Last updated
- 2017-01-10
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03016611. Inclusion in this directory is not an endorsement.